The QualityStocks Daily Wednesday, March 18th, 2020

Today's Top 3 Investment Newsletters

StockMarketWatch (BCRH) +584.78%

MarketClub Analysis (BMRA) +334.60%

Buzz Stocks (BWTX) +221.43%

The QualityStocks Daily Stock List

Fuling Global, Inc. (FORK)

Zacks, Financial Content, Stock Twits, MacroTrends, Capital Cube, StockInvest.us, Market Chameleon, Street Insider, FX Empire, PR Newswire, Super Stock Screener, Whale Wisdom, Infront Analytics, Nasdaq, Seeking Alpha, ChartMill, Investing.com, Morningstar, MarketBeat, Simply Wall St, MarketWatch and Barchart reported beforehand on Fuling Global, Inc. (FORK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Fuling Global, Inc. manufactures and distributes plastic and paper serviceware for the foodservice industry. It has six precision manufacturing facilities in the USA, Mexico, Indonesia and China. Fuling Global sells its products directly, and also through distributors to dealers, QSRs (Quick Service Restaurants), manufacturers, and retailers. Formed in 2015, Fuling Global is based in Wenling, the People's Republic of China (PRC). The Company’s shares trade on the NasdaqGS.

At present, Fuling Global has four factories in China and one in the United States with more than 1,500 employees. The yearly production capacity is about 50,000 tons including GPPS,PS,PP,PLA,PET.

Fuling Global’s plastic and paper serviceware products include disposable cutlery, drinking straws, cups, plates and other plastic and paper products. These products are used by greater than 100 customers primarily from the United States, China and Europe. These customers include Subway, Wendy's, Burger King, Taco Bell, KFC (China only), Walmart, and McKesson.

In 2019, Xinfu Hu, Chief Executive Officer of Fuling Global, stressed the importance of environmental protection in the foodservice sector while addressing the 23rd annual China Fast Food Industry conference, held in October of 2019 in Dalian, China. Hu's speech, titled, "Recycling, Benefiting the Earth -- International Tableware Environmental Protection Solution," focused on developing and implementing environmentally friendly solutions in the foodservice industry. This includes the use of completely biodegradable and recyclable products.

Last month, Fuling Global announced that its newest manufacturing facility, based in Semarang City, Central Java, Indonesia, officially opened and launched production of straws, sauce cups, take-out boxes and paper cups. The new facility is Fuling Global’s third manufacturing plant outside of China.

The new Indonesia manufacturing facility spans close to 194,000 square-feet. Fuling Global expects to install 64 production lines of manufacturing equipment in two phases during 2020. This includes 20 straw production lines; 12 cup lid and packing box production lines; eight sauce cup production lines; and 24 paper cup production lines. Later in 2020, Fuling Global plans to boost production to include paper bags.

Fuling Global, Inc. (FORK), closed Wednesday's trading session at $1.80, off by 8.1633%, on 3,721 volume with 19 trades. The average volume for the last 3 months is 3,618 and the stock's 52-week low/high is $1.79999995/$2.85999989.

chart

GrowLife, Inc. (PHOT)

Awesome Penny Stocks, Zacks, Stocks News Wire, Great Portfolio, Wall Street Alerts, Simply Wall St, Investor Ideas, CannabisMarketCap, Green Rush Review, Stockhouse, Stockopedia, Best Medical Marijuana Stocks, Stockwatch, Investors Underground, GlobeNewswire, Accesswire, Energy and Capital, InvestorsHub, TradingView, TMXmoney, Investing.com and CRWEWorld reported earlier on GrowLife, Inc. (PHOT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

GrowLife, Inc. is one of the nation’s most recognized indoor cultivation product and service providers. The Company provides farming soil, hydroponics equipment, organic plant nutrients, and other products to specialty grow operations in the USA. Its aim is to become the nation’s largest cultivation service provider for cultivating organics, herbs and greens and plant-based medicines. Formed in 2012, GrowLife is headquartered in Kirkland, Washington. Yesterday, GrowLife announced that its stock began trading on the OTCQB Market after successfully up-listing from the OTC Pink Market.

The Company has a complete selection of cultivation products combined with logistics and distribution services. Its focus is on helping responsible cultivation operations efficiently control supply costs, manage build-out investments, track supply usage, and streamline workflows.

GrowLife provides essential goods and services via a network of local representatives covering the U.S. and Canada, regional centers, and also its e-Commerce team. Its retail locations are in Encino, California; Portland, Maine; and Calgary, Alberta. In addition, the Company has its GrowLife Commercial operations.

Grow Life has launched a platform for its earlier majority acquired EZ-CLONE Enterprises, Inc. (EZ-CLONE) cloning and propagation company to serve as the commercial hemp cloning industry’s resource for innovation. The platform, ezclonehemp.com, is a trusted resource for cultivators to look for products and education on plant cloning and propagation, expressly designed for hemp growers. The Company received the patent for the design of its EZ-CLONE Pro Commercial Cloning System, “Aeroponics System with Rack and Tray”.

Earlier this month, GrowLife announced that it released to the public, via open source, its design and operation instructions for its concept GrowLife Cube vertical cannabis grow room product. This indoor cannabis growing facility takes advantage of state-of-the-art technology and design to maximize the amount of plants that can be grown in a cubic space. This is while employing technologies that reduce production costs and produce consistent results.

GrowLife Chief Executive Officer, Mr. Marco Hegyi, said, “As industry leaders whose primary mission is to help our customers achieve the most efficient growing practices, we knew that the best path forward to help our customers who are struggling with keeping costs as low as possible would be to release the plans to build our proprietary grow systems and offer all of the parts to build it through our suite of services, versus building an inventory and distributing them ourselves.”

GrowLife, Inc. (PHOT), closed Wednesday's trading session at $0.195, up 14.3695%, on 153,727 volume with 208 trades. The average volume for the last 3 months is 116,945 and the stock's 52-week low/high is $0.14/$1.32000005.

chart

Iota Communications, Inc. (IOTC)

Zacks, Market Wire News, Wall Street Reporter, Whale Wisdom, Real Investment Advice, last10k, Wallet Investor, Stockopedia, Dividend.com, Stockhouse, Market Screener, Street Insider, Investing.com, TradingView, InvestorsHub, Stockwatch, PR Newswire, Investors Hangout, and Investors Observer reported beforehand on Iota Communications, Inc. (IOTC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Iota Communications, Inc. is a wireless network carrier and software service company headquartered in New Hope, Pennsylvania. It provides Internet of Things (IoT) solutions that optimize energy efficiency, sustainability, as well as operations for commercial facilities. The Company provides data-driven insights for sustainability enabled by its network connectivity, advanced analytics platform, and software-as-a-service (SaaS) solutions for commercial and industrial markets across the U.S. Iota Communications’ shares trade on the OTC Markets Group’s OTCQB.

Additionally, the Company offers important ancillary products and services that facilitate the adoption of its subscription-based services. This includes solar energy, LED lighting, and HVAC implementation services. In essence, Iota Communications utilizes technology and connectivity to help businesses save money and become more sustainable.

Regarding Connecting, using its own 800 MHz FCC-licensed spectrum and multi-access gateways, the Company’s network is purpose built for the IoT. It offers superior building penetration, more reliable coverage, and secure data transmission.

Concerning Collecting, easy-to-install wireless sensors, meters and devices unlock valuable data from an organization’s existing infrastructure (Mechanical, Electrical and Environmental). This provides visibility into a company’s facility operations.

Pertaining to Analysis, Iota Communications’ BrightAI platform gives an organization the insights and alerts to increase operational visibility and proactively manage their facility. Therefore, a company can identify opportunities, improve performance, and share insights across teams and organizations.

Regarding Optimization, Iota’s platform (combining data and analytics) provides a continuous feedback loop. This optimizes energy efficiency, improves the performance of a firm’s operations, and drives substantial savings for a facility.

Iota Communications has acquired patented technology from Link Labs, Inc., a leading provider of low power, wide-area network technologies that power the Internet of Things (IoT). Link Labs has patented technology to form large-scale wireless IoT networks that can communicate data with thousands of devices at decreased costs, with quicker deployment, longer battery life and more reliability than competing solutions including cellular, Wi-Fi, and Zigbee.

Iota’s enterprise solutions rely heavily on asset digitization. This technology acquisition will enable billions of IoT devices to connect to the cloud, leveraging Iota's spectrum licenses.

Earlier this month, Iota Communications announced an update on the status of FCC spectrum license applications and granted licenses. Mr. Terrence DeFranco, President & Chief Executive Officer of IotaComm, said, "We are excited to announce that we have reached a significant milestone on granted FCC spectrum licenses and coverage capabilities. Currently, over 90 percent of our applications from the recent Public Notice have resulted in 800 MHz FCC license grants."

Iota Communications, Inc. (IOTC), closed Wednesday's trading session at $0.205, off by 2.381%, on 58,731 volume with 18 trades. The average volume for the last 3 months is 73,449 and the stock's 52-week low/high is $0.159999996/$0.75.

chart

Metallis Resources, Inc. (MTLFF)

OTC Markets, Corporate Knights, Supercharged Stocks, Smart Stock Trading Strategies, Gold Stock Data, Junior Mining Network, Penny Stock Hub, 4-Traders, Morningstar, YCharts, Market Screener, Wallet Investor, The Prospector News, Canadian Insider, Dividend Investor, PR Newswire, TradingView, Financial Buzz, Metals News, Barchart, Wallmine, Stockhouse, Canadian Mining Report, GuruFocus, InvestorX, OTC.Watch, MarketWatch, Seeking Alpha and Ceo.ca reported previously on Metallis Resources, Inc. (MTLFF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Metallis Resources, Inc. engages in the exploration and development of mineral properties in Canada. It chiefly explores for gold, copper, nickel, and silver deposits. The Company was previously known as Coltstar Ventures, Inc. It changed its name to Metallis Resources, Inc. in July of 2013. Metallis Resources has its corporate office in Vancouver, British Columbia.

The Company is focused on the exploration of gold, copper, nickel and silver at its 100 percent-owned Kirkham Property. This Property is located within the prolific Eskay Camp of the Golden Triangle, northwestern British Columbia. The Kirkham Property consists of 30 contiguous claims encompassing roughly 10,610 hectares.

Last month, Metallis Resources announced the second set of assay results from its 2019 drilling program. The Program has now expanded the Cliff porphyry copper-gold system northward for a strike length of 3 km along the 7.5 km Hawilson Monzonite Porphyry Complex at the Company’s Kirkham Property.

KH19-27, drilled 1.2 km to the north of Cliff, has now confirmed a 3 km long porphyry system of near surface bulk-tonnage style copper-gold mineralization between the Cliff and Miles zones. Gold-rich mineralization in KH19-27 correlates with massive sulphide veins along syn-mineral conjugate faults and breccias identified as future exploration targets. Interpretation of the updated 3D geological modelling has revealed two sub-parallel zones of copper-gold mineralization striking N15°E and dips approximately 70° to the east leaving a considerable gap of untested area open laterally and vertically.

Furthermore, Metallis Resources reports geological modeling and advanced porphyry vectoring and fertility tools (PVFTs), using chemical compositions of hydrothermal alteration zones is in progress to predict the likely direction and distance to mineralized centers. The results of the "PVFTs" combined with existing hyperspectral surveys and 3D models are being interpreted to discover the higher-grade core zones of the Cliff Porphyry system.

Metallis Resources' Vice President of Exploration, Mr. David Dupre, stated, "We are extremely proud of our early exploration achievements derived from only 17 drill holes at the Cliff Porphyry System. Rarely has a Porphyry Copper-Gold project with significant upside potential been advanced so rapidly".

Metallis Resources, Inc. (MTLFF), closed Wednesday's trading session at $0.083, off by 20.9524%, on 28,000 volume with 11 trades. The average volume for the last 3 months is 15,623 and the stock's 52-week low/high is $0.074/$0.75.

chart

New You, Inc. (NWYU)

Penny Stock Hub, CBD Today, Real Investment Advice, Investor Place, Insider Monkey, Wallet Investor, Investors Hangout, PR Newswire, Whale Wisdom, Business Insider, Barchart, Investing.com, Nasdaq, Dividend Investor, CIG News (Cannabis Investment Group), Stockopedia, InvestorsHub, TipRanks, Stockwatch, Market Screener, OTC.Watch, and MarketWatch reported earlier on New You, Inc. (NWYU), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

New You, Inc. presently holds one subsidiary, NEWYOU LLC. NEWYOU is working to secure a large share of the flourishing U.S. CBD (cannabidiol) market with its flagship product DROPS™. The Company markets and sells its products via multi-level marketing and a direct sales force to independent business owners. New You lists on the OTC Markets. The Company has its corporate headquarters in Carlsbad, California.

Ray and Daran Grimm, who have successfully built six multi-million dollar companies, founded New You, Inc. The Company states that its DROPS nano-CBD uses a proprietary nanoencapsulation technology to deliver superior bioavailability offering more efficacy than traditional CBD oils.

New You offers the above-mentioned DROPS, which is a canna-active CBD beverage enhancer; and also offers CB2 & CBD 2 Plus, a multi spectrum hemp-extracted CBD and hops-extracted beta-caryophyllene. It also offers Drops for pets; Caffe Canna, an organic cannabinoid-infused non-GMO dark roast coffee to promote weight loss; and Drops FX, a product to provide the us

r with an energy boost with a blend of canna-active vitamins B3, B6, B9, and B12. Furthermore, it offers Drops FX Sleep, a product to help users get sleep. The Company also offers Caffe714. This product offers the first-ever Nano CBD-infused product combo with targeted and clinically proven weight loss-activating ingredients. Moreover, New You’s product family includes The Cream, a multi-action 1000 mg CBD cream for inflammation, soreness, as well as being a moisturizer.

This month, New You announced that it has combined three lucrative market trends into one new product with the debut of NEWYOU Caffe Canna™. The debut of Caffe Canna is by New You, Inc.'s NEWYOU subsidiary. NEWYOU Caffe Canna™ is a dark roast instant coffee with two clinically proven weight loss ingredients and Canna-Active™ CBD all in one product.

Caffe Canna contains two clinically tested and patented active ingredients, SuperCitrimax® and ChromeMate®. These have been shown to be three times more effective than diet and exercise alone. Additionally, Caffe Canna includes other powerful natural ingredients, which may assist the body with fat burning, appetite suppression, blood sugar control, and more. Also, Caffe Canna includes a shot of 99 percent plus pure THC (Tetrahydrocannabinol)-Free Hemp-derived CBD.

Yesterday, New You announced that two World Champions were named to NEWYOU's Athletic Advisory Board. Two-time World Heavyweight Boxing Champion Chris Byrd and World UFC MMA Fighting Champion Guy Mezger have both put their names in the CBD ring with NEWYOU as part of the Company's new Athletic Advisory Board.

New You, Inc. (NWYU), closed Wednesday's trading session at $1.45, up 93.3333%, on 200 volume with 1 trade. The average volume for the last 3 months is 652 and the stock's 52-week low/high is $0.75/$25.00.

chart

Painted Pony Energy Ltd. (PDPYF)

Zacks, Speculating Stocks, Riverton Roll, Analyst Ratings, TMXmoney, Stockhouse, Morningstar, Dividend.com, YCharts, MacroTrends, Oil and Gas Investments Bulletin, InvestorsHub, Nasdaq, Wallet Investor, Smarter Analyst, MarketBeat, GuruFocus, Market Screener, Ceo.ca, Wallmine, Seeking Alpha and MarketWatch reported beforehand on Painted Pony Energy Ltd. (PDPYF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Painted Pony Energy Ltd. is a natural gas company mainly centered on the development of natural gas and natural gas liquids from the Montney formation in northeast British Columbia. Its philosophy is to grow via production development drilling for natural gas and natural gas liquids. Painted Pony Energy’s Montney gas is sweet gas with high heat content and no associated water production. The Company has entered into a 20-year strategic alliance with AltaGas Ltd. that provides for additional natural gas processing, marketing and egress solutions.

The Company was previously known as Painted Pony Petroleum Ltd. It changed its name to Painted Pony Energy Ltd. in May of 2017. Painted Pony Energy has its corporate headquarters in Calgary, Alberta. The Company lists on the OTC Markets.

The Montney is one of North America’s premier natural gas resource plays. The Montney formation surpasses 300 meters (roughly 1,000 feet) in total thickness over Painted Pony lands. It is a highly over-pressured reservoir, leading to an internally estimated volume of over 250 billion cubic feet of original gas-in-place per square mile.

These large gas volumes provide Painted Pony Energy with the opportunity to economically develop up to seven layers within the Montney zone and up to four wells per layer over its 292 net sections. The Company’s high working interest, contiguous land block encompasses 186,727 net acres of Montney rights.

This month, Painted Pony Energy announced Q4 and Full Year 2019 financial and operating results, 2019 year-end reserves, and improved cost structures. Selected highlights include closing the sale of a 75 percent working interest (WI) on 11,280 gross acres (8,460 net acres) in the South Townsend block during Q4 of 2019 for total cash consideration of $45 million; and decreasing bank debt at 2019 year end by 26 percent or $43 million to $120 million versus 2018 year-end bank debt of $163 million.

Moreover, drilling commenced this month on an eight-well Montney program by joint venture (JV) partner and project operator Tourmaline Oil Corp. on the 25 percent WI South Townsend block. In addition, Painted Pony Energy delivered a 2019 Proved Developed Producing (PDP) recycle ratio of 1.3 times, resulting in a three-year average PDP recycle ratio of 1.5 times. The Company also reduced Total Proved (1P) future development capital (FDC) by 11 percent or $172 million.

It expects to commence flowing production volumes this month through the new deep-cut facility at the AltaGas Townsend Facility that is expected to add around 1,200 bbls/d of natural gas liquids (NGLs), increasing Painted Pony Energy’s liquids yields to greater than 10 percent.

Painted Pony Energy Ltd. (PDPYF), closed Wednesday's trading session at $0.14, off by 33.0784%, on 69,400 volume with 21 trades. The average volume for the last 3 months is 12,167 and the stock's 52-week low/high is $0.137600004/$1.48000001.

chart

Sunstock, Inc. (SSOK)

OTC Dynamics, Penny Stock Base, last10k, StockPulse, StockInvest.us, TipRanks, Whale Wisdom, Central Charts, Market Wire News, Street Insider, Capital Cube, EIN News, Market Exclusive, Market Screener, OTC Markets, 4-Traders, InvestorsHub and Investors Hangout reported earlier on Sunstock, Inc. (SSOK), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Sunstock, Inc. operates a coin store that buys and sells precious metal coins and also an asset-backed set of cryptocurrencies backed by gold, silver, and platinum. It operates one precious metals retail store under Mom’s Silver Shop in Sacramento, California. Sunstock pursues a “ground to coin” strategy. Thus, it secures and/or acquires mining assets and also rights to purchase mining production, and sells these metals mainly through retail channels through their own branded coins. Formed in 2012, Sunstock is headquartered in Sacramento, California.

Sunstock is moving ahead with “Triple 8”, precious metal asset-backed Crypto Tokens. The Company is redefining how the world conceptualizes and uses money with the pending launch of asset-backed cryptocurrencies, which are directly tied to the value of gold bullion. “Triple 8” provides a value proposition for investors and end-users of the token.

Sunstock’s plan is to become a pure gold play stock, with plans to own a complete Vertical Integration in the gold industry. Its intention is to acquire mineral rights and gold mining assets to complement its robust and growing gold distribution business. The Company anticipates acquisition prices in the $5,000,000 to $10,000,000 range. The mines it is considering are producing upwards of 60,000 ounces of gold annually.

Sunstock states that it is in talks to acquire or partnership with a number of assets that could potentially produce billions in revenue over 5-10 years. The Company is centered on projects that already own substantial amounts of unrefined – but already mined – gold ore.

Mr. Jason Chang is the Founder, Chairman, Chief Executive Officer and Investor Relations Officer of Sunstock, Inc. Mr. Chang has more than 20 years of hospitality management experience. He began his career in the hospitality industry in the family business operating several hotels throughout California.

This week, Sunstock announced that it added to its existing precious metals sales and distribution strategy by targeting acquisitions in the gold mining industry. At the same time, It is working with its partners and advisors on a strategy to uplist to the OTC Markets Group’s OTCQB.

Sunstock, Inc. (SSOK), closed Wednesday's trading session at $0.0025, off by 10.7143%, on 535,536 volume with 8 trades. The average volume for the last 3 months is 6,222,609 and the stock's 52-week low/high is $0.000099999/$0.023499999.

chart

Driven Deliveries, Inc. (DRVD)

OTC Markets, BioPortfolio, Stock Price, CEO Road Show, InvestorsHub, Stock Sharks, Green Market Report, Financial News Media, YCharts, GlobeNewswire, Seeking Alpha, Simply Wall St, Dividend.com, MarketWatch, Stockhouse, Wallet Investor, TipRanks, Market Wire News, Investor Ideas, PR Newswire, Stockopedia, Dividend Investor, last10k, GuruFocus, and Investing.com reported previously on Driven Deliveries, Inc. (DRVD), and today we report the Company, here at the QualityStocks Daily Newsletter.

Driven Deliveries, Inc. is California's fastest growing online cannabis retailer and direct-to-consumer delivery company. It is the first publicly traded cannabis delivery service operating within the United States. The Company formerly went by the name Results-Based Outsourcing, Inc. It changed its name to Driven Deliveries, Inc. in September of 2018. Driven Deliveries is headquartered in San Diego, California.

The Company provides e-commerce solutions, online sales, as well as on-demand cannabis delivery in select cities where permitted by law. It offers legal cannabis consumers the ability to purchase and receive their marijuana fast and conveniently. The Company was established to bring movement and sustainable growth to the world's legal cannabis market.

Driven Deliveries works with brands and their products to be the all-in-one delivery solution to California, Nevada, and Oregon. Its business units comprise Driven Distribution - supply chain & distribution management; Ganjarunner - same day & next day scheduled delivery; and Budee (powered by Ganjarunner) - same day express delivery. In addition, business units include Fulfilled by Ganjarunner - direct to consumer brand solution; Mountain High (powered by Ganjarunner) - same day express delivery; and Weedwaves - app-based community for cannabis enthusiasts.

Recently, Driven Deliveries announced its Letter Of Intention (LOI) to purchase Northern California-based legacy cannabis distribution company, Humboldt Heritage, Inc. (HHI) and its subsidiaries Humboldt Sun Growers Guild LLC (HSGG) and Grateful Eight LLC (G8). This acquisition will spur a strong, synergistic alliance between the two California based cannabis companies. It will result in California's largest farm-to-consumer, vertically-integrated operator. The expectation is that this acquisition will add an additional $20M to Driven Deliveries’ 2020 Revenue forecast.

For Q4, Driven Deliveries announced considerable milestones attained. Through the quarter, it performed greater than 31,680 deliveries, acquired 2,587 new customers, and reduced the average new customer acquisition cost to $13.80 versus $22.16 in Q3. Furthermore, the Company was able to increase the aggregate gross margin from retail sales by 3 percent, reduce its average delivery expense by 6 percent via integration of its three delivery operations, and increase product selection on dynamic menus by 160 percent.

Driven Deliveries, Inc. (DRVD), closed Wednesday's trading session at $0.86, up 36.5079%, on 40,070 volume with 73 trades. The average volume for the last 3 months is 55,158 and the stock's 52-week low/high is $0.349999994/$3.49.

chart

Deep Yellow Limited (DYLLF)

Stock News Now, OilandGas360, TipRanks, Investing News, Macroaxis, Mining.com, MarketWatch, Market Screener, Wayne Weekly, Simply Wall St, ABN Newswire, InvestorsHub, TMXmoney, Seeking Alpha, 4-Traders, TradingView, Stockhouse, Stockwatch, and Wallet Investor reported earlier on Deep Yellow Limited (DYLLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Deep Yellow Limited operates as a uranium exploration and development company in Namibia. The Company’s strategy is based upon growing the existing uranium resources across its uranium projects in Namibia and the pursuit of accretive, counter-cyclical acquisitions to build a geographically varied asset portfolio. Deep Yellow lists on the OTC Markets Group’s OTCQX. The Company has its head office in Subiaco, Western Australia.

Deep Yellow holds four contiguous Exclusive Prospecting Licences (EPLs) encompassing 1,730km2 within the heart of what is a world recognized, prospective uranium province of high significance. These tenements are strategically positioned among the major uranium mines of the region – 20km south of the Husab/Rössing deposits and 40km southwest of the Langer Heinrich deposit.

Deep Yellow’s achievements include a landmark $4.5m earn-in joint venture (JV) by the Japanese group JOGMEC and the discovery of a new uranium deposit (Tumas 3) in April of 2017 during the early stages of a 10,000m drilling programme on Deep Yellow’s 100 percent owned ground. Manifold new targets remain to be tested along a 100km highly prospective palaeochannel system that has been identified.

Reptile Mineral Resources and Exploration (Pty) Ltd (RMR), is a wholly-owned subsidiary of Deep Yellow. Reptile manages the Reptile Project, the Nova Joint Venture, and the Yellow Dune Joint Venture encompassing 1,983km2. These projects contain resources totalling 126Mlb at 321ppm in the Measured, Indicated and Inferred categories at cut-offs varying between 100ppm and 250ppm U3O8.

The Reptile project includes two EPLs covering three alaskite type resources totalling 45Mlb at 420ppm U3O8 and four palaeochannel/calcrete resources totalling 63Mlb at 301ppm U3O8. Additionally, there are a number of exploration targets of palaeochannel/calcrete and alaskite-type.

The Yellow Dune JV includes one MDRL application encompassing a drilled-out uranium resource of the palaeochannel/calcrete type totalling 18Mlb U3O8 at 237ppm. Furthermore, the Nova JV includes two EPLs prospective for alaskite and palaeochannel/calcrete type uranium mineralization.

In August, Deep Yellow reported the completion of the exploration and resource upgrade drilling in the Tumas 1 East palaeochannel. Resource drilling along Tributary 5 on EPL 3497 was completed where drill densities are now adequate to undertake an Inferred Resource Estimation. Of note, exploration drilling has delineated a new zone of high-grade uranium mineralization at the convergence of Tributary 8 and the main Tumas channel. The EPL is held by Reptile Uranium Namibia (Pty) Ltd (RUN). All tributaries in the Tumas 1 East area have now been explored with resources established in Tributaries 1, 2, 4. Tributary 5 is now ready for resource estimation to commence.

Deep Yellow Limited (DYLLF), closed Wednesday's trading session at $0.11, up 37.50%, on 14,965 volume with 3 trades. The average volume for the last 3 months is 51,322 and the stock's 52-week low/high is $0.07/$0.320899993.

chart

CBD Life Sciences, Inc. (CBDL)

Emerging Growth, News to Watch, Investors News, OTC Markets, OTC.Watch, Globe Newswire, and Stockopedia reported previously on CBD Life Sciences, Inc. (CBDL), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

CBD Life Sciences, Inc.’s principal focus is to identify, evaluate and acquire undervalued opportunities with the aim of increasing shareholder value. The acquisition of LBC Bioscience, Inc. is the first in the CBD space. The Company is actively searching for additional opportunities within this developing sector. CBD Life Sciences lists on the OTC Markets. The Company is headquartered in Scottsdale, Arizona.

CBD Life Sciences announced this past March, that its wholly-owned subsidiary, LBC Bioscience, finalized the formulization for and is launching an organic - GMO free – CBD (cannabidiol) based anti-aging product line. The product line includes anti-aging day serum, CBD based eye gel, nourishing face serum with retinol, blemish balancing serum, CBD vitamin C face serum, and CBD based face cream. In addition, LBC Bioscience is working with Dr. Farhan Taghizadeh of Arizona Facial Plastics P.C. to develop a case study showing the effectiveness of the product line.

LBC Bioscience has also entered into negotiations to distribute its line of products in Japan. The initial order is $250,000. Ms. Lisa Nelson, President & Chief Executive Officer of CBD Life Sciences’ said this past April, “We are very excited about this opportunity to enter the Japanese market. The Japanese have embraced the benefits of CBD and we want to be on the forefront providing quality products to this aggressive expanding market.”

Recently, CBD Life Sciences announced that its LBC Bioscience completed the development of a disposable CBD vape-pen. This product is now undergoing final market testing. The anticipation is that it will be available for purchase within the next three to four weeks. LBC Bioscience is positioning itself to be a leader in the specialized CBD + e-cigarette vaping market.

CBD Life Sciences also recently announced that LBC Bioscience is continuing to experience substantial revenue growth due to the expansion and market acceptance of its product lines. LBC is experiencing growth in retail sales. Moreover, it now being approached to provide ‘white label’ versions of its product lines. LBC Bioscience has developed and is retailing/wholesaling a complete line of cannabidiol based organic products. These include hemp drops, massage oils, pain relief creams, anxiety and sleep supplements, CDB edibles, anti-aging skin solutions and a full line of CBD infused supplements for pets.

CBD Life Sciences, Inc. (CBDL), closed Wednesday's trading session at $0.0009, up 50.00%, on 23,890,398 volume with 79 trades. The average volume for the last 3 months is 4,626,073 and the stock's 52-week low/high is $0.000399999/$0.068400003.

chart

Whiting USA Trust II (WHZT)

Zacks, Street Insider, All Stocks Today, Wallstreet Online, Stockhouse, Global Banking and Finance, Simply Wall St, Marketbeat, MarketWatch, Barchart, and Dividend Investor reported previously on Whiting USA Trust II (WHZT), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Whiting USA Trust II holds a term net profits interest in the oil and gas producing properties located in the Permian Basin, Rocky Mountains, Gulf Coast, and Mid-Continent regions. Whiting USA Trust II is a subsidiary of Whiting Petroleum Corporation. The Company lists on the OTC Markets. Established in 2011, Whiting USA Trust II has its corporate office in Houston, Texas.

As of December 31, 2018, the Company’s oil and gas properties included interests in roughly 367.8 net producing oil and natural gas wells. These are situated in 46 predominately mature fields with established production profiles in 10 States.

Recently, Whiting USA Trust II announced that the Trust would make a distribution to unitholders in the second quarter of 2019. This relates to net profits generated during the first quarterly payment period of 2019. Unitholders of record on May 20, 2019 received a distribution of $0.140750 per unit that was payable on or before May 30, 2019.

The Trust’s net profits interest (NPI), the only asset of the Trust other than cash reserves held for future Trust expenses, represents the right to receive 90 percent of the net proceeds from Whiting Petroleum Corporation’s interests in certain existing oil and natural gas properties located mainly in the aforementioned Rocky Mountains, Permian Basin, Gulf Coast and Mid-Continent regions of the U.S.

As of March 31, 2019, on a cumulative accrual basis, 9.24 MMBOE (87 percent) of the Trust’s total 10.61 MMBOE have been produced and sold or divested. Based on the Trust’s reserve report for the underlying properties as of December 31, 2018, the projection is that the Trust’s 10.61 MMBOE will be produced prior to December 31, 2021, shortly after which the Trust would terminate. The 2018 year-end reserve report reflects expected annualized production decline rates of roughly 11.1 percent for oil and 23 percent for gas between 2019 and 2021.

The Company’s parent, Whiting Petroleum Corporation, is an independent oil and gas company. It develops, produces, acquires and explores for crude oil, natural gas and natural gas liquids mainly in the Rocky Mountains region of the U.S. The Company’s largest projects are in the Bakken and Three Forks plays in North Dakota and Montana and the Niobrara play in northeast Colorado.

Whiting USA Trust II (WHZT), closed Wednesday's trading session at $0.16, up 44.1441%, on 39,238 volume with 34 trades. The average volume for the last 3 months is 67,208 and the stock's 52-week low/high is $0.039999999/$1.875.

chart

Emergent Capital, Inc. (EMGC)

OTC Markets, MarketWatch, Simply Wall St, The Street, last10k, Stockhouse, Equity Clock, Zacks, Seeking Alpha, Barchart, Street Insider, Trading View, GuruFocus, Stockopedia, YCharts, 4-Traders, Market Screener, Financial Content, and InvestorsHub reported earlier on Emergent Capital, Inc. (EMGC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Emergent Capital, Inc. is a specialty finance company listed on the OTC Markets’ OTCQX. It invests in life settlements and is a worldwide leader in the life settlements industry. The Company has decades of experience creating value by way of the secondary and tertiary markets for life insurance policies. Emergent Capital established in 2006 as Imperial Holdings, LLC. The Company has been publicly traded since 2011. Emergent Capital is headquartered in Boca Raton, Florida. In 2015, shareholders voted to change the Company’s name to Emergent Capital, Inc.

Concerning Life settlements; they are an alternative asset class that can provide high uncorrelated returns. For investor consideration, life settlements have limited correlation to the stock market or the larger economic market. They can serve as a hedge against the volatility of more market-dependent investments. In addition, life settlements represent a compelling and diversified investment opportunity to include longevity risk in a portfolio.

Emergent Capital has access to a wide-ranging and proven network of life settlement brokers and third-party providers from whom it sources  attractive  and value-added policies. Essentially, Emergent Capital purchases individual policies and portfolios of life insurance policies. It manages these assets based on comprehensive actuarial and market data. Furthermore, an Emergent Capital subsidiary can act as a life settlement provider in over 30 States where it is able to pursue manifold opportunities within the life settlement space.

Emergent Capital’s goal is to produce a consistent flow of investment opportunities covering all facets of the life settlements market. These range from lending to outright purchases of portfolios, to tertiary trades, and also individual secondary market purchases.

This past November, Emergent Capital announced its financial results for the three month and nine month periods ended September 30, 2018. Q3 2018 financial highlights include Total Income from Continuing Operations of $29.7 million for the three month period ended September 30, 2018 versus $24.5 million for the same period in 2017. Income was impacted by a $20.1 million gain on the maturity of six policies during the quarter versus an $11.6 million gain on maturity of three policies for the same period the year prior.

Total Income from Continuing Operations was $40.9 million for the nine month period ended September 30, 2018 versus $53.5 million for the same period in 2017. Income was impacted by a $48.1 million gain on the maturity of 18 policies during the quarter versus a $30.6 million gain on maturity of 10 policies for the same period the year prior.

Emergent Capital, Inc. (EMGC), closed Wednesday's trading session at $0.33, up 37.50%, on 5,354,091 volume with 353 trades. The average volume for the last 3 months is 117,409 and the stock's 52-week low/high is $0.07/$0.430000007.

chart

ProGreen US, Inc. (PGUS)

Amigo Bulls, InvestorsHub, Market Exclusive, Morningstar, Stockhouse, Marketwired, Uptick Newswire, Investors Hangout, Insider Financial, Penny Stock Prodigy, Promotion Stock Secrets, Barchart, MarketWatch, GuruFocus, and GlobeNewswire reported earlier on ProGreen US, Inc. (PGUS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

ProGreen US, Inc. engages chiefly with investments in agricultural and real estate projects in Baja California, Mexico. The Company is concentrating on intensifying its property investments in Baja California, Mexico, through its joint venture (JV) partnership with Inmobiliaria Contel, and via its subsidiary Procon Baja JV.  ProGreen US is based in San Diego, California.

Concerning ProGreen US’s Baja Project, the Company entered into a JV with a Mexican landowner, Inmobiliaria Contel and has jointly created Pro Baja. This is its newest JV with ProGreen owning 51 percent and Inmobiliaria Contel 49 percent. ProGreen US established an office location in Ensenada. This office serves as headquarters for all of its activities in Baja California. At present, Contel is active in the high margin produce industry, growing crops for exporters to the U.S. market, with an abundance of land available for expansion under its JV partnership.

Moreover, 5,100 acres of land was acquired by Procon Baja JV, with 4.7 miles of oceanfront on the Bay of El Rosario, for which a master plan is being drawn for the development of a very large, completely green, global vacation and retirement community named "CieloMar." ProGreen US completed development of the first tract of land, which comprises roughly 300 acres. Of this, some 100 usable acres were cleared.

ProGreen US previously signed another agreement for a further 1,900 acres (500-800 usable for farming), and a 3-year option for 11,500 acres (1000-2500 usable for farming). The land, once developed and prepared, will be offered for long term lease (10-15 years), with the JV holding the title.

ProGreen US previously announced that it's subsidiary, Procon Baja JV (Procon), closed on the purchase and took possession of the new 2,500-acre tract of land in Baja California. The total purchase price is $160,000 (USD).

ProGreen Farms™ Rancho Arenoso is growing chili peppers on the approximately 100 acres now undergoing farming. It has plans for diversifying the operation with other types of produce for U.S. buyers as it expands onto the close by 2,500 acres that ProGreen's Mexican subsidiary, Procon Baja JV, acquired in June of 2018.

Recently, ProGreen US, in combination with its subsidiary, Procon Baja JV, executed a joint venture (JV) alliance contract with real estate giant EXIT Corp International's most successful regional franchise owners of EXIT Southeast. Exit Southeast (EXIT) will coordinate U.S. operations and initiate strategic sales/marketing of Cielo Mar Baja California Resort Sales.

This deal will target and deploy EXIT's 11,000-plus agents, with an extensive database of buyers/investors to commence presales corporate wide, throughout their connected 800 offices in the U.S. and Canada. The Exclusive Contract with EXIT Realty starts March 1, 2019. It gives EXIT access to Cielo Mar’s 10,000-plus unit inventory of Single Family Homes and Multi-Family Condos over the course of the 4 1/2 mile, 5000 acre oceanfront development.

ProGreen US, Inc. (PGUS), closed Wednesday's trading session at $0.0003, up 50.00%, on 360,000 volume with 4 trades. The average volume for the last 3 months is 953,088 and the stock's 52-week low/high is $0.000199999/$0.002099999.

chart

Barsele Minerals Corp. (BRSLF)

Stockhouse, Stock Press Daily, The Stock Talker, TradingView, The Wall Street Review, and MarketWatch reported on Barsele Minerals Corp. (BRSLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 2013, Barsele Minerals Corp. is a junior mineral exploration company headquartered in Vancouver, British Columbia. The Company has a notable gold, silver, and copper exploration project on renowned mineral trends in Sweden (the Barsele Gold Project). Its advanced-stage Barsele Gold Project is near Storuman, Västerbottens Län, which is roughly 600 kilometers north of Stockholm, Sweden. Barsele Minerals’ shares trade on the OTC Markets Group’s OTCQB.

The Company’s management team is a part of the Belcarra Group. This team has received recognition for the discovery of Orko Silver Corp.’s La Preciosa Silver-Gold Deposit in Durango, Mexico, among other discoveries.

Barsele Minerals is a joint venture (JV) partner with Agnico Eagle on the Barsele Gold Project. Agnico Eagle owns 55 percent and Barsele Minerals owns 45 percent. Agnico Eagle has an option to increase to 70 percent through taking the Project to Pre-Feasibility (Ongoing). Furthermore, Orex Minerals, Inc. holds a 2 percent NSR (Net Smelter Return) that can be purchased for US $5M. All exploration costs prior to Pre-Feasibility are covered by Agnico Eagle.

The Barsele Gold Project is in a region with current and past producers. These are Boliden, Kristineberg, Bjorkdal, and Svartliden. Barsele Minerals also has additional JVs in Sweden, as well as knowledgeable and well connected staff already in Scandinavia.

For 2017, Agnico Eagle considerably increased exploration and the drilling program over the prior year. Infill drilling continues to connect Avan, Central and Skirasen zones extending the main area of mineralization to greater than 3 kilometers. Drilling at Risberget, 3.7 kilometers to the southeast of Skirasen, yielded 4 significant gold hits and metallurgical testing yielded recovery rates of more than 92 percent.

In November, Barsele reported an operational update for the continuing exploration program within the Barsele Gold-VMS Project area in Västerbottens Län, northern Sweden. Nine holes were reported, of which six were expansion, two were infill and one was a regional test. One hole was abandoned because of bad ground conditions.

Since the start of drilling in late 2015 and until the end of the month of September 2017, 86,310 meters of core has been collected from 191 drill holes. Base of till sampling is ongoing.

Agnico Eagle's recent surface extension trenching program was completed. Structural mapping along the 90.0 meter by 15.0 meter corridor validates the existing gold distribution model and provides detailed information on quartz veining and reactivation of the different shearing and mineralization orientations. The information will help with the continuing modeling of the gold deposit.

Barsele Minerals Corp. (BRSLF), closed Wednesday's trading session at $0.13764, up 84.257%, on 2,000 volume with 1 trade. The average volume for the last 3 months is 2,200 and the stock's 52-week low/high is $0.074699997/$0.547259986.

chart

The QualityStocks Company Corner

Champignon Brands Inc. (CSE: SHRM)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands Inc. (CSE: SHRM) is a Canadian-based, research-driven company specializing in the formulation of mushroom-infused CPGs that promote holistic health and wellness. On March 2, 2020, the company saw its first day of trading on the Canadian Securities Exchange (CSE). Committed to sustainability, all SHRM products are organic, non-GMO and vegan certified.

Champignon Brands Inc. (CSE: SHRM) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRM), closed Wednesday's trading session at $0.33, even for the day. The stock's 52-week low/high is $0.33/$0.33.

Recent News

chart

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF)

The QualityStocks Daily Newsletter would like to spotlight Exro Technologies Inc. (OTCQB: EXROF).

Canadian technology company Exro Technologies (CSE: XRO) (OTCQB: EXROF) is a groundbreaking innovator operating in the energy sector. A recent article discussing the company reads, “Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability. To view the full article, visit http://nnw.fm/iNcx8

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability.

Applications

Exro’s technology and efficiency optimization algorithms improve the performance and efficiency of electric motors by manipulating power delivery to individual coils, thereby enabling the ability to expand operating parameters. This novel approach is scalable and can be utilized in most variable torque applications.

The widespread applications of Exro’s technology apply to optimizing the performance of electric vehicles, locomotive traction applications, industrial motors, and other variable torque applications that benefit from smart energy conversion.

Intellectual Property

Exro’s proprietary, patented software controls electric motor coils through individual coil switching. This introduction of intelligence into energy conversion at the level of individual coils results in expanded speed/torque capability, improved machine efficiency, reliability, safety and maintenance across a wider operating range. Exro’s advanced control algorithms create smart, real-time optimized power management.

Exro currently holds 15 patents, with 8 patents pending and additional patents under development. The company continues to expand its IP portfolio to support its goal of becoming a globally recognized leader in leveraging advanced control algorithms to improve the performance, efficiency and longevity of electric motors and generators.

Market Opportunity

Electric motors are the single biggest consumer of electricity. They account for about two-thirds of industrial power consumption and about 45% of global power consumption, according to an analysis by the International Energy Agency. Exro’s technology seeks to give industries a new way to look at energy—from electric vehicles, to industrial equipment, to renewable applications like wind farms; we are improving the way energy is consumed.

Laboratory Expansion

The 6,500-square-foot Exro Innovation Center (EIC), scheduled to open spring of 2020 in Calgary, will transition the current Victoria lab into one Calgary based center. The company’s new laboratory space will expand its service capabilities to customers, provide larger test capabilities, and showcase how Exro’s technology can be applied to dramatically improve the performance of electrical motors.

The EIC will also host collaborative events to explore advances in energy consumption and electric motor innovations, with participants from across Canada and around the world.

Strategic Partnerships

  • A strategic agreement with Finland’s Aurora Powertrains Oy, which in 2019 released an all-electric production snowmobile called the “eSled,” will see Exro’s technology added to the Aurora electric powertrain. The snowmobile sector’s economic footprint is estimated at $26 billion in the U.S., $8 billion in Canada, and $5 billion in Europe and Asia.
  • An agreement with Potencia in Mexico serving the last mile vehicle segment will integrate Exro’s custom drive and EPM module into small passenger commercial vehicles (taxis) and fleet delivery trucks
  • A licensing agreement with Motorino Electric, a leader in the Canadian electric transportation industry, will integrate Exro’s Electric Power Module technology into Motorino’s CTi electric bicycle.

Management

Chief Executive Officer Sue Ozdemir is a proven leader in the innovation and manufacturing of electric motors. She has nine years of accomplishments at General Electric, acting as CCO and the CEO of GE’s Small Industrial Motors Division, overseeing the division’s North American and international markets – ultimately building the division into a $160 million enterprise.

Chief Commercial Officer Josh Sobil is leading the seamless adoption of Exro’s growing product portfolio focused on the mobility segment and opening doors in all segments including agriculture, heavy industry, energy, construction, among others.

Executive Chairman Mark Godsy is a serial technology entrepreneur who has been involved in many top tier ventures, including two of Canada’s most successful biotech companies.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), closed Wednesday's trading session at $0.165, off by 8.4859%, on 149,964 volume with 66 trades. The average volume for the last 3 months is 140,499 and the stock's 52-week low/high is $0.124389998/$0.522899985.

Recent News

chart

InsuraGuest Technologies, Inc. (TSX.V: ISGI)

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Technologies, Inc. (TSX.V: ISGI).

InsuraGuest Technologies Inc. (TSX- V: ISGI) is pleased to announce the launch of its new division, InsuraGuest Risk Purchasing Group, LLC (InsuraGuest RPG). InsuraGuest RPG, has received its certificate of approval from the State of Nevada Division of Insurance, which allows the Company’s group of unassociated businesses, hotels and vacation rentals with similar risk profiles to take advantage of a joint insurance purchase.

InsuraGuest Technologies, Inc. (TSX.V: ISGI) is a SaaS (Software-as-a-Service) company utilizing its proprietary flagship insurtech software platform, InsuraGuest, to provide hotels, resorts and vacation rental properties with a specialized Hospitality Liability insurance policy. The platform and policy combination help transfer the exposure to liability away from the client/property while guests benefit from potential accident and loss coverage during their stay.

The Hospitality Liability policy is offered through integration of InsuraGuest’s API with the clients’ property management systems. InsuraGuest’s platform is currently capable of integrating with approximately 71 different hotel and vacation rental property management systems, giving it access to millions of rooms worldwide.

InsuraGuest continues to pursue expansion opportunities in the United States, and has plans to expand to its distribution platform and Hospitality Liability policy to the United Kingdom and Europe regions by third quarter 2020, as well as expansion into Asia by the end of 2020.

Protecting Guests, Enhancing Customer Experience

InsuraGuest is the first line of defense for both the property and the guest.

InsuraGuest is purchased by the hotel or vacation rental “property,” which automatically extends the policy to each registered guest and its occupants at check-in, for an additional nightly fee. The specialized Hospitality Liability policy affords coverage for accidental in-room property damage, theft of personal property, as well as accidental medical, and accidental death and dismemberment.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights stayed in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion stayed nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United States, where there approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s combined demographics will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit that are not the properties fault.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Hospitality Liability policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Investment Consideration

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a Bachelor of Science in consumer studies with an emphasis in architecture as an undergraduate at the University of Utah. He subsequently earned his MBA. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Logan Anderson, CFO & Director
Logan Anderson (bachelor’s degree in communications, accounting and economics) holds the designation of ACA with the Chartered Accountants of Australia and New Zealand. He began his career as an associate chartered accountant in New Zealand and then Canada. This was followed by his position as controller of a management services company which was responsible for the management of numerous private and publicly traded companies. Since 1993, Anderson has served as president of Amteck Financial Corp. (and its predecessors), a private financial consulting services company servicing both private and public companies. He is a former director of 3D Systems, Inc. (NYSE: DDD), and was formerly a founder, officer, and director of Worldbid.com. Anderson has also been involved in raising funds for numerous private and public companies in all stages of their development and has been an officer and director for numerous public and private companies over the past 40 years.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends. Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Tony Sansone, COO & VP of Finance
Tony Sansone has over 30 years of financial, operations and business development experience which includes serving as CFO in the health care, foodservice distribution, manufacturing and technology sectors, including public company experience. He has held senior finance positions in the banking, telecommunications, medical products, and food & drug retailer industries, closing over $430 million of private debt, equity and line of credit financings and over $350 million of a merger, acquisitions, real estate and state incentive transactions, including due diligence, negotiations, closing, and integration. Sansone coordinated and was the executive sponsor for four ERP implementations and multiple other best-in-class software & technology solutions. He received his MBA from the University of Utah and a Bachelor of Science in accounting from Utah State University. Sansone also currently serves as president-elect of the Utah Chapter of Financial Executives International and a past president and current member of the board of trustees for Catholic Community Services of Utah. He is the proud father of three children.

Christopher J. Panos, Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018 and as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Jennifer Epperson, Vice President of Sales
Jennifer Epperson has over 20 years of B2B sales experience with exceptional success history. She has grown and developed sales territories across multiple industries. Her ability to find and develop strategic relationships has given her top-level performance throughout her career. Epperson’s passion and knowledge provide an inherent ability to connect and retain relationships for the growth of the company. Throughout her professional career, she has achieved peak performance sales results and awards year after year. She captures the vision of the company and drives it forward with enthusiasm and expertise. Her commitment to providing an exceptional customer experience has been the key to her success.

Richard Matthews, Interim Financial Controller
Richard Matthews joined the InsuraGuest team in March 2019 as the interim financial controller. Leading the Finance and Audit team, Matthews is responsible for the delivery of financial services such as accounting, treasury, reporting, budgeting and insurance management, in accordance with legislative requirements and organizational policies and strategies. He has over 30 years of experience in providing professional services across a broad range of finance areas including compliance, business process, audit, and financial reporting. He holds a degree in accounting from the University of Utah and is a licensed CPA in the state of Utah.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.

Jim Kilduff, Board Advisor
James “Jim” C. Kilduff has nearly 40 years of experience in the insurance and risk management sectors. He is a dynamic and energetic team leader and builder with extensive experience in the changes affecting the insurance business through Gas, alternative distribution, insurtechs and program business. His skillset includes experience as chief insurance officer with Outdoorsy Insurance Group, CEO with Harbor Hill Solutions Inc., and senior vice president and chief marketing officer with State National Insurance Companies. His career has spanned MGA creation and management, insurance company management, business development and underwriting, primary insurance and reinsurance.

Don Archibald, Board Advisor
Don Archibald brings to InsuraGuest’s advisory board 54 years of experience as an insurance agent. Archibald is the founder and former owner of Archibald Clarke and Defieux (ACD Insurance), as well as the co-founder and former equity partner of Sussex Insurance, and an agent with Sussex since 2014.

InsuraGuest Technologies, Inc. (TSX.V: ISGI), closed Wednesday's trading session at $0.165, even for the day, on 430 volume with 1 trade. The average volume for the last 3 months is 11,291 and the stock's 52-week low/high is $0.07/$0.100000001.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced the completion of its research and development phase for its Hemp You Can Feel(TM) line of sweeteners and coffee creamers. To view the full press release, visit http://cnw.fm/8Dhdb

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Wednesday's trading session at $0.14, up 6.8702%, on 1,201 volume with 4 trades. The average volume for the last 3 months is 15,336 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs Inc. (NASDAQ: SGLB), the sole provider of in-process quality-assurance software for the commercial 3D metal printing industry, has been awarded a contract by Northwestern University to implement its patented PrintRite3D(R) software. The company’s real-time, melt-pool analytics technology is set to transform the commercial additive-manufacturing space by addressing costly quality control issues – a step required to maximize profits and move forward from the prototype phase to widespread industrialization. Also today, NetworkNewsWire released a report on the company detailing how SGLB is revolutionizing the supply-chain dynamics for the 3D-metal-printing industry with its in-process, quality-control software solution. To view the full article, visit http://nnw.fm/A1TOd

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Wednesday's trading session at $2.56, off by 13.8047%, on 21,367 volume with 138 trades. The average volume for the last 3 months is 68,155 and the stock's 52-week low/high is $2.30999994/$18.50.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) was featured today in the 420 with CNW by CannabisNewsWire. For many, the legalization of recreational marijuana might as well have been trumpets loudly declaring the end of times. Arguments against it ranged aplenty, with some claiming it is a gateway drug while others claimed it would result in increased crime rates. But what many hadn’t considered was the effect it would have on real estate.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Wednesday's trading session at $0.24, off by 14.2857%, on 161,583 volume with 61 trades. The average volume for the last 3 months is 107,647 and the stock's 52-week low/high is $0.229499995/$1.34000003.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced that it has not been subject to material supply chain disruptions due to COVID-19. According to the update, the company continues to fulfill purchase orders and has inventory ordered for Q2 delivery. To view the full press release, visit http://nnw.fm/X49b6

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Wednesday's trading session at $0.1139, off by 8.88%, on 25,500 volume with 7 trades. The average volume for the last 3 months is 154,768 and the stock's 52-week low/high is $0.101999998/$0.429100006.

Recent News

chart

National Storm Recovery Inc. (OTC: NSRI)

The QualityStocks Daily Newsletter would like to spotlight National Storm Recovery Inc. (NSRI).

National Storm Recovery Inc. (OTC: NSRI), through its subsidiaries, including National Storm Recovery, LLC (DBA Central Florida Arbor Care and Mulch Manufacturing, Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

National Storm and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

National Storm’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

National Storm in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing, Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides National Storm with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

National Storm’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

National Storm plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as the company’s flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow National Storm’s debris hauling division to realize significant savings on its transportation costs.

National Storm has chosen as its new headquarters the Mulch Manufacturing 100,000-square-foot building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing, Inc. and National Storm Recovery, LLC, and has ample room to expand as the needed.

Leadership

National Storm’s Sustainable Green Team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

National Storm Recovery Inc. (OTC: NSRI), closed Wednesday's trading session at $0.49, up 104.1667%, on 900 volume with 6 trades. The average volume for the last 3 months is 610 and the stock's 52-week low/high is $0.0982/$3.00.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Wednesday's trading session at $1.41, up 6.015%, on 3,102 volume with 16 trades. The average volume for the last 3 months is 20,026 and the stock's 52-week low/high is $0.600600004/$4.0300002.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Wednesday's trading session at $2.26, up 3.1963%, on 34,525 volume with 318 trades. The average volume for the last 3 months is 75,026 and the stock's 52-week low/high is $1.04999995/$5.8499999.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Wednesday's trading session at $0.102, up 0.790514%, on 19,629 volume with 19 trades. The average volume for the last 3 months is 60,080 and the stock's 52-week low/high is $0.100000001/$0.50999999.

Recent News

chart

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Wednesday's trading session at $4.65, off by 9.5419%, on 1,508 volume with 31 trades. The average volume for the last 3 months is 16,268 and the stock's 52-week low/high is $2.0999999/$10.5600004.

Recent News

chart

Jerrick Media Holdings, Inc. (OTC: JMDA)

The QualityStocks Daily Newsletter would like to spotlight Jerrick Media Holdings, Inc. (OTC: JMDA).

Jerrick Media Holdings, Inc. (OTC: JMDA) develops technology-based solutions to solve digital problems. Through the combination of design, thought and data analysis, the company builds products that influence a worldwide audience.

Jerrick’s flagship product is Vocal, a proprietary long-form digital publishing platform that provides storytelling tools and engaged communities for creators to get discovered and fund their creativity.

Vocal

Designed to develop and cost-effectively engage content creators, the Vocal platform enables its over 500,000 registered content creators to reach an engaged audience and monetize their content. In addition to providing relevant content, Vocal’s technology is centered on efficiency and scalability through its niche digital communities, as well as output through its data-driven distribution strategy.

Vocal partners with content creators and brands that recognize difficulties inherent in the digital advertising space and that can benefit from branded content marketing opportunities available on publishing platforms like Vocal.

All content available on Vocal is created within the platform’s custom editor and published on one of Vocal’s embedded genre-specific communities, spanning topics that range from food to wellness, beauty, technology and more.

In May 2019, Jerrick launched Vocal+, its premium subscription membership program. Vocal+ members pay a membership fee for premium value-added features, including receiving increased earnings for their content, reduced platform processing fees for tips received, a Vocal+ badge on their creator page, access to new features on the Vocal Platform, and other rewards. Creators can sign up for free or upgrade to Vocal+, available for purchase on either an annual or monthly subscription basis.

 

Vocal for Brands

Vocal for Brands is an in-house creative studio that generates actionable data from bespoke native advertising campaigns. Vocal for Brands partners with direct-to-consumer (DTC) to create beautiful, campaign-optimized stories on Vocal that build brand affinity, trust and drive results.

Additionally, Jerrick provides a Managed Services offering to business-to-business (B2B) and business-to-consumer (B2C) product and service brands which encompasses a full range of digital marketing and e-commerce solutions. Managed Services includes the setup and ongoing maintenance of clients’ websites, Amazon and Shopify storefronts and listings, social media pages, search engine marketing, and other various tools and sales channels utilized by e-commerce sellers for sales and growth optimization. In addition to partnering with Managed Services clients, the company offers a range of la carte services.

Growth Strategy

Upon the consummation of its anticipated listing on the Nasdaq Capital Market, Jerrick intends to change its official company name to “Creatd, Inc.,” subject to stockholder approval.

This rebranding will initiate Jerrick’s go-forward growth strategy and its plans to expand its offerings and provide technology products and resources for creators to help transform their ideas into reality. The strategic plan is designed to greatly increase Jerrick’s potential market value via a plethora of new revenue streams.

Creatd will focus on a community of creators that number more than 2.5 billion users, for which it will offer democratized, transparent platforms for distribution, sentiment, resources and monetization. The company’s agile development process will rely on a combination of bleeding-edge technology that eliminates barriers and creates efficiencies. Superior design thinking and data analysis will allow Creatd to expand its digital footprint to a global community.

Creatd will partner with a community of technology collaborators and sophisticated investors who collaborate to provide technology solutions for creators, brands and their respective audiences. The company’s solutions, business processes, technology platforms and design theories will lend themselves to application opportunities on a global scale.

History & Management

Jerrick was founded in 2012. Initially a private media company providing online content through a portfolio of brands, Jerrick’s needs quickly outpaced its initial technology and product offering. In 2015, Jerrick partnered with Thinkmill, a premiere, Australia-based product design and development group to create a content management system (CMS) for its brands; that system evolved into the company’s flagship product, Vocal.

Today, Jerrick’s management team is an impressive group of abstract thinkers united by their passion to solve problems. Leading the team are founder and CEO Jeremy Frommer, and Justin Maury, Jerrick’s president and head of product.

Frommer’s career includes two decades in the financial technology industry, working as a hedge fund and portfolio manager, as well as on the sell-side of the financial industry. Frommer started NextGen Trading, a software development company building proprietary equity trading platforms. NextGen was acquired by Carlin Financial Group of which Frommer became CEO. RBC Capital Markets Corporation eventually bought Carlin. At RBC, Frommer was managing director, head of the Global Prime Services group and a member of the RBC Global Equities Operating Committee.

Maury joined Jerrick in 2013, bringing with him 10 years of experience in the creative industry. Since partnering with Frommer to establish Jerrick, Maury led the company’s product development for more than four years. His passion for the creative arts and technology ultimately yielded the vision for Vocal. During the Jerrick’s early formative years, Maury was a driving force in creating the vision, design and architecture for the Vocal platform and managing the oversight of technology development.

Jerrick Media Holdings, Inc. (JMDA), closed Wednesday's trading session at $3.05, off by 8.9552%, on 1,750 volume with 7 trades. The average volume for the last 3 months is 880 and the stock's 52-week low/high is $1.63999998/$5.00.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Wednesday's trading session at $1.375, off by 9.5395%, on 156,509 volume with 549 trades. The average volume for the last 3 months is 461,300 and the stock's 52-week low/high is $1.25/$8.50.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.